| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.37 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |